US FDA Approves New Alzheimer’s Drug – The St Kitts Nevis Observer


By Justine Coleman The Hill   The US Food and Drug Administration (FDA) on Monday granted approval for the first new Alzheimer’s treatment since 2003. The decision comes as the debate over whether to approve Biogen’s drug Aducanumab has stirred controversy, with some Alzheimer’s experts and an independent advisory committee opposing approval saying there’s not […]
Next Post

Global Inequalities: 'COVID-19 Crisis Demands Human-Centred Policies'- ILO Director-General - The St Kitts Nevis Observer

The ILO’s Director-General told delegates at the opening virtual plenary sitting of the International Labour Conference that human-centred policies, such as those outlined in the ILO Centenary Declaration, are key to a sustainable and inclusive global pandemic response Geneva (ILO NEWS)  The “cataclysmic” effect of the COVID-19 pandemic on the […]